Trial intelligence / Profile preview

Prospective Evaluation of Oral Alkalinization by Urologists and Nephrologists

NCT03035812Phase 4Completed

Start
Feb 2017
Primary completion
Feb 2020
Countries
1
01

Overview

Phase 4, open-label, single-arm trial in metabolic acidosis and nephrolithiasis. Primary endpoint: Variation in the extracellular compartment at Month 3. Started Feb 2017; status: completed.

02

Conditions

metabolic acidosisnephrolithiasis

Beyond the preview

Go deeper on NCT03035812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03035812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call